80% of Kids Undergoing ADHD Treatment Receive Stimulant Meds

80% of Kids Undergoing ADHD Treatment Receive Stimulant Meds

An increasing number of children are visiting their doctor for treatment of attention deficit/hyperactivity disorder (ADHD), and along with it, the number of prescriptions for drugs, particularly stimulants, used to treat the condition.

New data from the Centers for Disease Control and Prevention found that in 2013, an average of 6.1 million visits to a physician, pediatrician or psychiatrist by children between the ages of 4 and 13 were for diagnosed ADHD. That accounts for 6% of all doctor visits by that population. In 2003, that figure was 4%.

Whether more kids actually have ADHD or are being misdiagnosed with the disease is up for debate.

The CDC data brief also found that 8 out of 10 ADHD doctor visits for those aged between 4 and 12 resulted in a prescription for a stimulant drug, such as Adderall (amphetamine/dextroamphetamine), Ritalin (methylphenidate) and Focalin (dextroamphetamine). A similar rate was found for ADHD visits for those aged between 13 and 17.

The new research also showed that boys were twice as likely to visit a doctor for ADHD as girls. The figure for boys is 147 visits per 1,000 compared with 62 per 1,000 for girls.


Jonathan Block

Jonathan Block

Jonathan Block is a freelance writer and former MedShadow content editor. He has been an editor and writer for multiple pharmaceutical, health and medical publications, including BioCentury, The Pink Sheet, Modern Healthcare, Health Plan Week and Psychiatry Advisor. He holds a BA from Tufts University and is earning an MPH with a focus on health policy from the CUNY Graduate School of Public Health & Health Policy.


Did you find this article helpful?


Latest News

Can Convalescent Plasma Treat COVID-19 Patients?

Can Convalescent Plasma Treat COVID-19 Patients?

One of the most promising treatments for COVID-19 is convalescent plasma, a component of blood. People who have been infected with the virus and are now healthy have developed COVID-19-fighting antibodies, which, the theory is, can be given to people currently sick with COVID-19 so that those antibodies can boost…

  • Advertisement